SEC Form N-PORT · 2026-04-30
PILL ETF Holdings
Direxion Daily Pharmaceutical & Medical Bull 3X Shares reported 65 holdings. Weights reproduce the source and may not sum to exactly 100 because of cash, derivatives, rounding, liabilities, or other positions.
- Report date
- 2026-04-30
- SEC accession
- 0001193125-26-287436
- Series ID
- S000050532
- Source
- SEC Form N-PORT
All reported holdings
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|---|---|---|---|
| GOLDMAN FINANCIAL | GOLDMAN FINANCIAL | 18.989318% | 2,448,305.62 | 2,448,305.62 PA |
| N/A | N/A | 5.117994% | 659,866.37 | 1 NC |
| DREYFUS GOVERNMENT CASH MANAGE | DREYFUS GOVERNMENT CASH MANAGE | 3.748355% | 483,277.88 | 483,277.88 PA |
| OGN | ORGANON & COMPANY | 2.770431% | 357,193.5 | 26,958 NS |
| CORT | CORCEPT THERAPEUTICS INC | 1.845203% | 237,903.28 | 5,114 NS |
| ELVN | ENLIVEN THERAPEUTICS INC | 1.797188% | 231,712.6 | 5,620 NS |
| AXSM | AXSOME THERAPEUTICS INC | 1.741849% | 224,577.75 | 1,081 NS |
| OMER | OMEROS CORP | 1.637778% | 211,159.8 | 14,463 NS |
| PRGO | PERRIGO COMPANY PLC | 1.615146% | 208,241.92 | 17,588 NS |
| DFTX | DEFINIUM THERAPEUTICS INC | 1.571455% | 202,608.8 | 9,260 NS |
| NKTR | NEKTAR THERAPEUTICS | 1.55199% | 200,099.12 | 2,353 NS |
| TRVI | TREVI THERAPEUTICS INC | 1.542269% | 198,845.76 | 14,451 NS |
| TERN | TERNS PHARMACEUTICALS INC | 1.514448% | 195,258.77 | 3,689 NS |
| 2624324 | INDIVIOR PHARMACEUTICALS INC | 1.499662% | 193,352.46 | 5,257 NS |
| PCRX | PACIRA BIOSCIENCES INC | 1.494043% | 192,627.93 | 7,557 NS |
| HROW | HARROW INC | 1.468038% | 189,275.1 | 4,670 NS |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1.465994% | 189,011.62 | 931 NS |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | 1.453038% | 187,341.18 | 5,993 NS |
| RPRX | ROYALTY PHARMA PLC | 1.43552% | 185,082.55 | 3,695 NS |
| AMLX UW | AMYLYX PHARMACEUTICALS INC | 1.434073% | 184,896 | 11,556 NS |
| VTRS | VIATRIS INC | 1.431303% | 184,538.88 | 12,352 NS |
| CRNX | CRINETICS PHARMACEUTICALS INC | 1.403448% | 180,947.48 | 4,666 NS |
| ANIP | ANI PHARMACEUTICALS INC | 1.393896% | 179,715.9 | 2,262 NS |
| LGND | LIGAND PHARMACEUTICALS INC | 1.388118% | 178,971 | 780 NS |
| MBX | MBX BIOSCIENCES INC | 1.374929% | 177,270.52 | 5,866 NS |
| INVA | INNOVIVA INC | 1.372118% | 176,908.05 | 7,695 NS |
| LQDA | LIQUIDIA CORP | 1.360619% | 175,425.54 | 4,474 NS |
| AMRX | AMNEAL PHARMACEUTICALS INC | 1.355071% | 174,710.25 | 13,575 NS |
| XERS UW | XERIS BIOPHARMA HOLDINGS INC | 1.354638% | 174,654.38 | 28,515 NS |
| BMY | BRISTOL-MYERS SQUIBB COMPANY | 1.351555% | 174,256.84 | 2,876 NS |
| EWTX | EDGEWISE THERAPEUTICS INC | 1.336798% | 172,354.32 | 5,567 NS |
| OCUL | OCULAR THERAPEUTIX INC | 1.319918% | 170,177.94 | 18,162 NS |
| PFE | PFIZER INC | 1.309003% | 168,770.7 | 6,321 NS |
| NUVB | NUVATION BIO INC | 1.297441% | 167,279.95 | 37,591 NS |
| ZTS | ZOETIS INC | 1.284968% | 165,671.77 | 1,441 NS |
| ELAN | ELANCO ANIMAL HEALTH INC | 1.27647% | 164,576.09 | 7,357 NS |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 1.267256% | 163,388.12 | 4,844 NS |
| JNJ | JOHNSON & JOHNSON | 1.265746% | 163,193.5 | 710 NS |
| MRK | MERCK & COMPANY INC | 1.257515% | 162,132.3 | 1,485 NS |
| ALMS | ALUMIS INC | 1.254505% | 161,744.19 | 6,551 NS |
| LLY | ELI LILLY & COMPANY | 1.246803% | 160,751.2 | 172 NS |
| TARS | TARSUS PHARMACEUTICALS INC | 1.21812% | 157,053.09 | 2,469 NS |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 1.206974% | 155,616 | 3,242 NS |
| PAHC | PHIBRO ANIMAL HEALTH CORP | 1.200699% | 154,806.98 | 2,911 NS |
| EYPT | EYEPOINT INC | 1.183929% | 152,644.8 | 11,564 NS |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC | 1.162825% | 149,923.84 | 2,662 NS |
| AMPH | AMPHASTAR PHARMACEUTICALS INC | 1.133337% | 146,121.84 | 6,654 NS |
| TBPH | THERAVANCE BIOPHARMA INC | 1.020001% | 131,509.44 | 7,856 NS |
| PHAT | PHATHOM PHARMACEUTICALS INC | 1.012799% | 130,580.8 | 11,659 NS |
| RAPP | RAPPORT THERAPEUTICS INC | 1.010109% | 130,234.03 | 3,931 NS |
| ESPR | ESPERION THERAPEUTICS INC | 0.995062% | 128,294 | 64,147 NS |
| CRMD | CORMEDIX INC | 0.953675% | 122,958 | 16,200 NS |
| N/A | N/A | 0.879199% | 113,355.68 | 1 NC |
| ARVN | ARVINAS INC | 0.812544% | 104,761.8 | 10,582 NS |
| BIOA | BIOAGE LABS INC | 0.805706% | 103,880.25 | 6,165 NS |
| ZVRA | ZEVRA THERAPEUTICS INC | 0.748883% | 96,553.98 | 9,494 NS |
| MAZE | MAZE THERAPEUTICS INC | 0.705264% | 90,930.18 | 3,421 NS |
| SEPN | SEPTERNA INC | 0.692912% | 89,337.6 | 3,760 NS |
| WVE | WAVE LIFE SCIENCES LTD | 0.671006% | 86,513.24 | 12,254 NS |
| LBRX | LB PHARMACEUTICALS INC | 0.640936% | 82,636.26 | 2,606 NS |
| FULC | FULCRUM THERAPEUTICS INC | 0.594376% | 76,633.24 | 10,748 NS |
| AQST | AQUESTIVE THERAPEUTICS INC | 0.557932% | 71,934.5 | 17,545 NS |
| ANRO | ALTO NEUROSCIENCE INC | 0.426503% | 54,989.38 | 2,143 NS |
| N/A | N/A | 0.218868% | 28,218.8 | 1 NC |
| GOLDMAN SACHS LIQ ES FD A | GOLDMAN SACHS LIQ ES FD A | 0% | 0 | 0 PA |